MedPath

M-Vizion™ Macroscopic Radiographic Study

Recruiting
Conditions
Revision Hip Arthroplasty
Registration Number
NCT05721859
Lead Sponsor
Medacta USA
Brief Summary

Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.

Detailed Description

The aim of this study is to evaluate the M-Vizion modular stem performance in patients who undergo total hip replacement according to the standard practice. It is expected that subjects receiving revision hip arthroplasty with the Medacta M-Vizion™ modular hip stem will have less than 5mm of stem subsidence at 2 years.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).
  • Ability to understand and provide written authorization for use and disclosure of personal health information.
  • Subjects who are able and willing to comply with the study protocol and follow-up visits.
  • Patients requiring a revision total hip replacement.
  • Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use.
  • Male and female patients ages 21 - 80 years of age at the time of surgery.
Exclusion Criteria
  • Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • Patients with a systemic or metabolic disorder leading to progressive bone deterioration.
  • Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and/or fixation to the prosthesis.
  • Patients with an active or suspected latent infection in or about the hip joint.
  • Patients that are incarcerated.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
subsidence2 year post-op visit (± 6 months)

Occurrence of subsidence \>5mm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

Geisinger Medical Center

🇺🇸

Danville, Pennsylvania, United States

Northwestern Medicine

🇺🇸

Chicago, Illinois, United States

New England Baptist Hospital

🇺🇸

Boston, Massachusetts, United States

Dartmouth Health

🇺🇸

Lebanon, New Hampshire, United States

OrthoCarolina Research Institute, Inc.

🇺🇸

Charlotte, North Carolina, United States

University of Utah Department of Orthopaedics

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath